{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:36:19Z","timestamp":1762508179260},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10096-020-03833-8","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T10:03:43Z","timestamp":1594202623000},"page":"1159-1167","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Levels of evidence supporting European and American community-acquired pneumonia guidelines"],"prefix":"10.1007","volume":"39","author":[{"given":"Jo\u00e3o","family":"Ferreira-Coimbra","sequence":"first","affiliation":[]},{"given":"Sof\u00eda","family":"Tejada","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Campogiani","sequence":"additional","affiliation":[]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"3833_CR1","doi-asserted-by":"crossref","unstructured":"Al-Abri SS, Al-Maashani S, Memish ZA, Beeching NJ (2012) An audit of inpatient management of community-acquired pneumonia in Oman: a comparison with regional clinical guidelines. J Infect Public Health","DOI":"10.1016\/j.jiph.2012.03.002"},{"key":"3833_CR2","unstructured":"Triantafyllidis C, Kapordelis V, Papaetis GS, Orphanidou D, Apostolidou M, Nikolopoulos I et al (2012) Guidelines adherence for patients with community acquired pneumonia in a Greek hospital. Eur Rev Med Pharmacol Sci"},{"key":"3833_CR3","doi-asserted-by":"crossref","unstructured":"Men\u00e9ndez R, Torres A, Zalaca\u00edn R, Aspa J, Mart\u00edn-Villasclaras JJ, Border\u00edas L et al (2005) Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med","DOI":"10.1164\/rccm.200411-1444OC"},{"key":"3833_CR4","doi-asserted-by":"crossref","unstructured":"Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D (2006) Improved clinical outcomes with utilization of a community-acquired pneumonia guideline. Chest","DOI":"10.1378\/chest.130.3.794"},{"key":"3833_CR5","doi-asserted-by":"crossref","unstructured":"Fanaroff AC, Califf RM, Windecker S, Smith SC, Lopes RD Levels of Evidence Supporting American College of Cardiology\/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA J Am Med Assoc:2019","DOI":"10.1001\/jama.2019.1122"},{"key":"3833_CR6","doi-asserted-by":"crossref","unstructured":"Meyer C, Bowers A, Wayant C, Checketts J, Scott J, Musuvathy S et al (2018) Scientific evidence underlying the American College of Gastroenterology\u2019s clinical practice guidelines. PLoS One","DOI":"10.1371\/journal.pone.0204720"},{"key":"3833_CR7","doi-asserted-by":"crossref","unstructured":"Zhang Z, Hong Y, Liu N (2018) Scientific evidence underlying the recommendations of critical care clinical practice guidelines: a lack of high level evidence. Intensive Care Med","DOI":"10.1007\/s00134-018-5142-8"},{"key":"3833_CR8","doi-asserted-by":"crossref","unstructured":"Lee DH, Vielemeyer O (2011) Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines. Arch Intern Med","DOI":"10.1001\/archinternmed.2010.482"},{"issue":"Suppl 6","key":"3833_CR9","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","volume":"17","author":"M Woodhead","year":"2011","unstructured":"Woodhead M, Blasi F, Ewig S, Garau J, Huchon G, Ieven M et al (2011 Nov) Guidelines for the management of adult lower respiratory tract infections--full version. Clin Microbiol Infect 17(Suppl 6):E1\u2013E59","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"3833_CR10","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200(7):e45\u2013e67","journal-title":"Am J Respir Crit Care Med"},{"key":"3833_CR11","doi-asserted-by":"crossref","unstructured":"Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC et al (2007) Infectious Diseases Society of America\/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis","DOI":"10.1086\/511159"},{"key":"3833_CR12","doi-asserted-by":"crossref","unstructured":"Woodhead M, Blasi F, Ewig S, Huchon G, Leven M, Ortqvist A et al (2005) Guidelines for the management of adult lower respiratory tract infections. Eur Respir J","DOI":"10.1183\/09031936.05.00055705"},{"key":"3833_CR13","unstructured":"Jacobs AK, Kushner FG, Ettinger SM, Guyton RA, Anderson JL, Ohman EM et al (2013) ACCF\/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines. Circulation"},{"key":"3833_CR14","doi-asserted-by":"crossref","unstructured":"Atkins D, Eccles M, Flottorp S, Guyatt GH, Henry D, Hill S et al (2004) Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. BMC Health Serv Res","DOI":"10.1186\/1472-6963-4-38"},{"key":"3833_CR15","doi-asserted-by":"crossref","unstructured":"Barnett AS, Lewis WR, Field ME, Fonarow GC, Gersh BJ, Page RL et al (2017) Quality of evidence underlying the American Heart Association\/American College of Cardiology\/Heart Rhythm Society guidelines on the management of atrial fibrillation. JAMA Cardiol","DOI":"10.1001\/jamacardio.2016.4936"},{"key":"3833_CR16","doi-asserted-by":"crossref","unstructured":"Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC (2009) Scientific evidence underlying the ACC\/AHA clinical practice guidelines. JAMA J Am Med Assoc","DOI":"10.1001\/jama.2009.205"},{"key":"3833_CR17","doi-asserted-by":"crossref","unstructured":"Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA (2013) AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology.","DOI":"10.1002\/hep.26578"},{"key":"3833_CR18","doi-asserted-by":"crossref","unstructured":"Witkowski M, Wilkinson L, Webb N, Weids A, Glah D, Vrazic H (2018) A systematic literature review and network meta-analysis comparing once-weekly Semaglutide with other GLP-1 receptor agonists in patients with type 2 diabetes previously receiving 1\u20132 Oral anti-diabetic drugs. Diabetes Ther","DOI":"10.1007\/s13300-018-0424-2"},{"key":"3833_CR19","doi-asserted-by":"crossref","unstructured":"Mathenge PG, Low SK, Vuong NL, Mohamed MYF, Faraj HA, Alieldin GI et al (2019) Efficacy and resistance of different artemisinin-based combination therapies: a systematic review and network meta-analysis. Parasitol Int","DOI":"10.1016\/j.parint.2019.04.016"},{"key":"3833_CR20","doi-asserted-by":"crossref","unstructured":"Turpen RM, Fesperman SF, Sultan S, Borawski KM, Norris RD, Klink J et al (2010) Levels of evidence ratings in the urological literature: an assessment of interobserver agreement. BJU Int","DOI":"10.1111\/j.1464-410X.2009.09181.x"},{"key":"3833_CR21","doi-asserted-by":"crossref","unstructured":"Ramalho JN, Tedesqui G, Ramalho M, Azevedo RS, Castillo M (2015) Evidence levels for neuroradiology articles: Low agreement among raters. Am J Neuroradiol","DOI":"10.3174\/ajnr.A4242"},{"key":"3833_CR22","doi-asserted-by":"crossref","unstructured":"Bhandari M, Swiontkowski MF, Einhorn TA, Tornetta P, Schemitsch EH, Leece P et al (2004) Interobserver agreement in the application of levels of evidence to scientific papers in the American volume of the Journal of Bone and Joint Surgery. J Bone Joint Surg Am","DOI":"10.2106\/00004623-200408000-00016"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03833-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-020-03833-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03833-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T02:21:02Z","timestamp":1612491662000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-020-03833-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["3833"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03833-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"9 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Rello has served as consultant and in the speakers\u2019 bureau for Nzbriva, MSD, Pfizer & Astellas. The remaining authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}